Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing Effectiveness of Smoking Cessation Intervention During Low Dose CT Screening for Lung Cancer
NCT03059940Phase 1Active, not recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 2017
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in nicotine dependence (3 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Smoking Abstinence Rate at 6 months. Started Jun 2017; status: active, not recruiting.
02
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT03059940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03059940.